Oleogel-S10 reduced the need for daily dressing changes compared with a control gel in patients with epidermolysis bullosa, according to a further analysis of data from the phase 3 EASE study.
Patients with EB experienced substantial reductions in affected skin area with continued use of the bark-derived topical agent oleogel-S10 in an open-label extension study.